When gliomas were analyzed based on their type and grade, low ZNF554 expression associated with shorter survival of anaplastic AC (grade III, p < 0.05) and GBM (grade IV, p < 0.05) patients (including a subgroup of IDH-wildtype GBMs, p < 0.05), but not with the survival of patients of the two ODG groups and the grade II AC group (Figure 2D–F). Here, ZNF554 is linked to glioblastoma.